Cargando…
Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
The pathogenesis of Alzheimer’s disease (AD) is somewhat complex and has yet to be fully understood. As the ef-fectiveness of the therapy currently available for AD has proved to be limited, the need for new drugs has become increas-ingly urgent. The modulation of the endogenous cannabinoid system (...
Autores principales: | Giuseppina, Talarico, Alessandro, Trebbastoni, Giuseppe, Bruno, Carlo, Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343203/ https://www.ncbi.nlm.nih.gov/pubmed/29962346 http://dx.doi.org/10.2174/1570159X16666180702144644 |
Ejemplares similares
-
External Validity of Randomized Controlled Trials on Alzheimer’s Disease: The Biases of Frailty and Biological Aging
por: Canevelli, Marco, et al.
Publicado: (2017) -
The Impact of Frailty on the Risk of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: Evidences from a 5-Year Observational Study
por: Trebbastoni, Alessandro, et al.
Publicado: (2017) -
Impact of the Cannabinoid System in Alzheimer's Disease
por: Li, Shuangtao, et al.
Publicado: (2023) -
Altered Cortical Synaptic Plasticity in Response to 5-Hz Repetitive Transcranial Magnetic Stimulation as a New Electrophysiological Finding in Amnestic Mild Cognitive Impairment Converting to Alzheimer’s Disease: Results from a 4-year Prospective Cohort Study
por: Trebbastoni, Alessandro, et al.
Publicado: (2016) -
Promoting the Assessment of Frailty in the Clinical Approach to Cognitive Disorders
por: Canevelli, Marco, et al.
Publicado: (2017)